eMedicine Specialties > Pediatrics: Surgery > General Surgery

Diaphragmatic Hernias

Author: Nicola Lewis, MBBS, FRCS, Specialist Registrar, Department of Surgery, Birmingham Children's Hospital, UK
Coauthor(s): Philip Glick, MD, MBA, Professor, Departments of Surgery, Pediatrics, and Gynecology and Obstetrics, Vice-Chairperson for Research and Development, Department of Surgery, State University of New York at Buffalo
Contributor Information and Disclosures

Updated: Oct 27, 2008

Introduction

History of the Procedure

In 1679, Lazarus Riverius (1589-1655) recorded the first reported case of a congenital diaphragmatic hernia (CDH); this was following postmortem examination of a 24-year-old male.1 The first attempt at surgical repair for congenital diaphragmatic hernia was by Nauman of Sweden in 1888; the 19-year-old patient presented with acute respiratory distress and an acute abdomen, and a laparotomy was performed. In 1889, J. O'Dwyer, MD, carried out the first repair of congenital diaphragmatic hernia in an infant. The first successful repair occurred in 1905. The patient was aged 9 years, and Heidenhain (at the Municipal Hospital for Worms, Germany) reduced the hernia and closed the diaphragmatic defect through a midline laparotomy incision. Approximately 20 years later, Carl Hedbolm reported a 58% mortality rate for patients undergoing surgical intervention for congenital diaphragmatic hernia.

In 1940, William Ladd and Robert Gross based their diagnosis of congenital diaphragmatic hernia on history, physical examination findings, and findings on chest radiography with or without a barium meal.2 They advocated early surgical intervention (within the first 48 h). Gross also described a 2-staged closure of the abdominal wall in difficult cases; closure of skin and subcutaneous fascia at the initial surgery and closure of the abdominal wall 5-6 days later. In 1950, C. Everett Koop and Julian Johnson suggested the transthoracic approach as a means of closing the defect under more direct vision.3

As surgical expertise improved, innovative strategies were developed to address large diaphragmatic defects and agenesis of the hemidiaphragm. These techniques included the use of rotational muscle flaps, perirenal fascia, and synthetic patch repairs.

The exponential elucidation of the pathophysiology of congenital diaphragmatic hernia was instrumental in improving the survival rate in infants. Congenital diaphragmatic hernia was no longer considered a primarily surgical disease but rather a disease associated with pulmonary hypoplasia, pulmonary hypertension, pulmonary immaturity, and an increased susceptibility of the lungs to ventilation-induced lung injury. This led to a delayed approach to surgical repair and to a gentle but more ingenious respiratory support.

Problem

Associated anomalies are present in 10-50% of patients with congenital diaphragmatic hernias; these anomalies confer a 2-fold relative risk of mortality when compared with patients with isolated congenital diaphragmatic hernias.4 Frequently associated anomalies include cardiac defects, chromosomal anomalies (ie. trisomies 21, 18, and 13), renal anomalies, genital anomalies, and neural tube defects.

Frequency

Congenital diaphragmatic hernia occurs in 1 per 3000 live births.5

Mortality

The Congenital Diaphragmatic Hernia Study Group recorded a 63% survival rate in 1995-1996 based on data from 62 centers in North America, Europe, and Australia.6 Survival rates are 60-90% for patients who present within the first few hours of life (see Media file 1).7

Etiology

Relevant embryology

The diaphragm is derived from 4 embryonic structures: the septum transversum, the pleuroperitoneal membranes, mesoderm of the body wall, and esophageal mesenchyme. Following folding of the fetal head at 4-5 weeks' gestation, the septum transversum comes to lie as a semicircular shelf, which separates the heart from the liver. The septum transversum does not completely separate the thoracic cavity from the peritoneal cavity but allows pericardioperitoneal canals to exist on either side of the esophagus.

During the fifth week of gestation, the pleuroperitoneal membranes develop along a line connecting the root of the 12th rib with the tips of the 7th to 12th ribs. The pleuroperitoneal membranes grow ventrally to fuse with the posterior margins of the septum transversum and the dorsal mesentery of the esophagus. Hence, at 6-7 weeks' gestation, the pleuroperitoneal canals are closed; the left closes after the right. The mesentery of the esophagus condenses to form the left and right crura of the diaphragm, and the mesoderm of the body wall forms the outer rim of diaphragmatic muscle.

The posterolateral diaphragmatic defect is postulated to result from failure of closure of the pleuroperitoneal canals. The canal remains open when the intestines return to the abdomen at 10 weeks' gestation. Some intestine and other viscera enter the thorax and lead to compression of the developing lung at the crucial pseudoglandular stage and shifting of the mediastinum to the contralateral side. This causes compression of the heart and the contralateral lung as well.

In 1984, Iritani proposed a different concept of diaphragmatic development. He suggested that a posthepatic mesenchymal plate develops between the septum transversum and the pericardioperitoneal canals.8 Lateral growth of this plate leads to closure of the pericardioperitoneal canals, and congenital diaphragmatic hernia results from a disturbance in growth of the posthepatic mesenchymal plate.

Causes

  • Genetic factors: The initiating factor responsible for the development of congenital diaphragmatic hernia is unknown. Wide variations have been noted in the reported prevalence of chromosomal abnormalities (7-31%) in patients with congenital diaphragmatic hernia. The prevalence is higher in cases of congenital diaphragmatic hernia associated with other defects.5 Familial occurrence has been noted in fewer than 2% of cases.
  • Other causes: The role of drugs and environmental chemicals in the development of congenital diaphragmatic hernia is uncertain, but nitrofen, quinine, thalidomide, phenmetrazine, and polybrominated diphenyls have been used to induce congenital diaphragmatic hernia in various species. Current investigations are exploring the link between congenital diaphragmatic hernia and defects in the retinoid signaling pathway in experimental models.

Pathophysiology

The pathophysiology of congenital diaphragmatic hernia involves pulmonary hypoplasia, pulmonary hypertension, pulmonary immaturity, and potential deficiencies in the surfactant and antioxidant enzyme system.

Because of bowel herniation into the chest during crucial stages of lung development, airway divisions are limited to the 12th to 14th generation on the ipsilateral side and to the 16th to 18th generation on the contralateral side. Normal airway development results in 23-35 divisions. Because airspace development follows airway development, alveolarization is similarly reduced.

Development of the pulmonary arterial system parallels development of the bronchial tree, and, therefore, fewer arterial branches are observed in congenital diaphragmatic hernia. Abnormal medial muscular hypertrophy is observed as far distally as the acinar arterioles, and the pulmonary vessels are more sensitive to stimuli of vasoconstriction.9 Pulmonary hypertension resulting from these arterial anomalies leads to right-to-left shunting at atrial and ductal levels. This persistent fetal circulation leads to right-sided heart strain or failure and to the vicious cycle of progressive hypoxemia, hypercarbia, acidosis, and pulmonary hypertension observed in the neonatal period.

The surfactant system is demonstrably deficient in the lamb model of congenital diaphragmatic hernia.10 Postnatal administration of surfactant in these lambs is associated with dramatic increases in gas exchange, lung compliance, and pulmonary blood flow. However, in human neonates, reports on the status of the surfactant system are inconsistent.11,12

Infants with congenital diaphragmatic hernias also have impairment of the pulmonary antioxidant enzyme system and are more susceptible to hyperoxia-induced injury.

In addition, a left ventricular smallness and hypoplasia are observed with congenital diaphragmatic hernia. This is believed to arise from decreased in utero blood flow to the left ventricle, the mechanical compression of the herniated viscus similar to that observed in the lungs, and/or a primary yet unidentified developmental defect that simultaneously causes the diaphragmatic hernia and lung problems.

Presentation

Prenatal

The diagnosis of congenital diaphragmatic hernia is frequently made prenatally prior to 25 weeks' gestation.

Congenital diaphragmatic hernia is usually detected in the antenatal period (46-97%), depending on the use of level II ultrasonography techniques. Ultrasonography reveals polyhydramnios, an absent intra-abdominal gastric air bubble, mediastinal shift, and hydrops fetalis. Ultrasonography demonstrates the dynamic nature of the visceral herniation observed with congenital diaphragmatic hernia. The visceral hernia has moved in and out of the chest in several fetuses.

Differential diagnoses on prenatal ultrasonography are as follows:

Postnatal

History and clinical findings vary with the presence of associated anomalies and the degree of pulmonary hypoplasia and visceral herniation. In the infant presenting in the neonatal period without prenatal diagnosis, variable respiratory distress and cyanosis, feeding intolerance, and tachycardia are noted.

In the physical examination, the abdomen is scaphoid if significant visceral herniation is present (see Media file 2).

Upon auscultation, breath sounds are diminished, bowel sounds may be heard in the chest, and heart sounds are distant or displaced.

Late presentation

Patients may present outside of the neonatal period with intestinal obstruction, bowel ischemia, and necrosis following volvulus.

Indications

No time for repair of congenital diaphragmatic hernia (CDH) is ideal, but the authors suggest that the window of opportunity is 24-48 hours after birth to achieve normal pulmonary arterial pressures and satisfactory oxygenation and ventilation on minimal ventilator settings.

Relevant Anatomy

The diaphragm is a musculotendinous structure that separates the thoracic cavity from the abdominal cavity. It is composed of a central nonmuscular portion (central tendon) surrounded by a muscular rim in addition to the right and left diaphragmatic cura. The right and left diaphragmatic cura are 2 muscular bands that originate from vertebral bodies L1-L3 and L1-L2 respectively. These muscular bands insert into the dorsomedial diaphragm.

Most diaphragmatic defects are posterolateral, with 85-90% of these occurring on the left. The label "posterolateral" may be a misnomer because, frequently, much larger areas of the diaphragm are missing and only a posterior rim of muscle can be found. A hernial sac is present in 10-20% of cases.

The Morgagni defect occurs posterior to the sternum and results from failure of sternal and costal fibers to fuse at the site where the superior epigastric artery crosses the diaphragm. The Morgagni defect is rare and is rarely a cause for surgery in the newborn.

Contraindications

The association of congenital diaphragmatic hernia (CDH) with lethal congenital abnormalities is a relative contraindication to repair of the diaphragmatic defect.

More on Diaphragmatic Hernias

Overview: Diaphragmatic Hernias
Workup: Diaphragmatic Hernias
Treatment: Diaphragmatic Hernias
Follow-up: Diaphragmatic Hernias
Multimedia: Diaphragmatic Hernias
References

References

  1. Irish MS, Holm BA, Glick PL. Congenital diaphragmatic hernia. A historical review. Clin Perinatol. Dec 1996;23(4):625-53. [Medline].

  2. Ladd WE, Gross RE. Congenital diaphragmatic hernia. N Engl J Med. 1940;223:917-25.

  3. Koop CE, Johnson J. Transthoracic repair of diaphragmatic hernia in infants. Ann Surg. Dec 1952;136(6):1007-11. [Medline].

  4. Tonks A, Wyldes M, Sommerset DA, et al. Congenital malformations of the diaphragm: findings of the West Midlands congenital anomaly register 1995 to 2000. prenatal diagnosis. 2004;24:596-604. [Medline].

  5. Torfs CP, Curry CJ, Bateson TF, Honore LH. A population-based study of congenital diaphragmatic hernia. Teratology. Dec 1992;46(6):555-65. [Medline].

  6. Clark RH, Hardin WD Jr, Hirschl RB, et al. Current surgical management of congenital diaphragmatic hernia: a report from the Congenital Diaphragmatic Hernia Study Group. J Pediatr Surg. Jul 1998;33(7):1004-9. [Medline].

  7. Downard C, Jaksic T, Garza J, et al. Analysis of an improved survival rate for congenital diaphragmatic hernia. Journal of Pediatric Surgery. 2003;38:729-732. [Medline].

  8. Iritani I. Experimental study on embryogenesis of congenital diaphragmatic hernia. Anat Embryol (Berl). 1984;169(2):133-9. [Medline].

  9. Koivusalo AI, Pakarinen MP, Lindahl HG, Rintala RJ. The cumulative incidence of significant gastroesophageal reflux in patients with congenital diaphragmatic hernia-a systematic clinical, pH-metric, and endoscopic follow-up study. J Pediatr Surg. Feb 2008;43(2):279-82. [Medline].

  10. Glick PL, Pohlson EC, Resta R, et al. Maternal serum alpha-fetoprotein is a marker for fetal anomalies in pediatric surgery. J Pediatr Surg. Jan 1988;23(1 Pt 2):16-20. [Medline].

  11. Janssen DJ, Tibboel D, Carnielli VP, et al. Surfactant phosphatidylcholine pool size in human neonates with congenital diaphragmatic hernia requiring ECMO. J Pediatr. Mar 2003;142(3):247-52. [Medline].

  12. Lotze A, Knight GR, Anderson KD, et al. Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg. Mar 1994;29(3):407-12. [Medline].

  13. Fauza DO, Wilson JM. Congenital diaphragmatic hernia and associated anomalies: their incidence, identification, and impact on prognosis. J Pediatr Surg. Aug 1994;29(8):1113-7. [Medline].

  14. Bagolan P, Casaccia G, Crescenzi F, Nahom A, Trucchi A, Giorlandino C. Impact of a current treatment protocol on outcome of high-risk congenital diaphragmatic hernia. J Pediatr Surg. Mar 2004;39(3):313-8; discussion 313-8. [Medline].

  15. Chess PR. The effects of gentle ventilation on survival in congenital diaphragmatic hernia. Pediatrics. 2004;113:917. [Medline].

  16. Reyes C, Chang LK, Waffarn F, Mir H, Warden MJ, Sills J. Delayed repair of congenital diaphragmatic hernia with early high-frequency oscillatory ventilation during preoperative stabilization. J Pediatr Surg. Jul 1998;33(7):1010-4; discussion 1014-6. [Medline].

  17. Ng GY, Derry C, Marston L, Choudhury M, Holmes K, Calvert SA. Reduction in ventilator-induced lung injury improves outcome in congenital diaphragmatic hernia?. Pediatr Surg Int. Feb 2008;24(2):145-50. [Medline].

  18. Bos AP, Tibboel D, Hazebroek FW, Molenaar JC, Lachmann B, Gommers D. Surfactant replacement therapy in high-risk congenital diaphragmatic hernia. Lancet. Nov 16 1991;338(8777):1279. [Medline].

  19. Glick PL, Leach CL, Besner GE, et al. Pathophysiology of congenital diaphragmatic hernia. III: Exogenous surfactant therapy for the high-risk neonate with CDH. J Pediatr Surg. Jul 1992;27(7):866-9. [Medline].

  20. Colby CE, Lally KP, Hintz SR, et al. Surfactant replacement therapy on ECMO does not improve outcome in neonates with congenital diaphragmatic hernia. Journal of Pediatric Surgery. 2004;39(11):1632-7. [Medline].

  21. Karamanoukian HL, O'Toole SJ, Glick PL. "State-of-the-art" management strategies for the fetus and neonate with congenital diaphragmatic hernia. J Perinatol. Mar-Apr 1996;16(2 Pt 2 Su):S40-7. [Medline].

  22. Scaife ER, Johnson DG, Meyers RL, Johnson SM, Matlak ME. The split abdominal wall muscle flap--a simple, mesh-free approach to repair large diaphragmatic hernia. J Pediatr Surg. Dec 2003;38(12):1748-51. [Medline].

  23. Okazaki T, Hasegawa S, Urushihara N, et al. Toldt's fascia flap: a new technique for repairing large diaphragmatic hernias. Pediatr Surg Int. Jan 2005;21(1):64-7. [Medline].

  24. Masumoto K, Nagata K, Souzaki R, Uesugi T, Takahashi Y, Taguchi T. Effectiveness of diaphragmatic repair using an abdominal muscle flap in patients with recurrent congenital diaphragmatic hernia. J Pediatr Surg. Dec 2007;42(12):2007-11. [Medline].

  25. Wilson JM, Bower LK, Lund DP. Evolution of the technique of congenital diaphragmatic hernia repair on ECMO. J Pediatr Surg. Aug 1994;29(8):1109-12. [Medline].

  26. St Peter SD, Valusek PA, Tsao K, et al. Abdominal complication related to type of repair of congenital diaphragmatic hernia. Journal of surgical research. 2007;140(2):234-236. [Medline].

  27. Lally KP, Bagolan P, Hosie S, et al. Corticosteroids for fetuses with congenital diaphragmatic hernia: can we show benefit?. Journal of Pediatric Surgery. 2006;41(4):668-674. [Medline].

  28. Becmeur F, Reinberg O, Dimitriu C, Moog R, Philippe P. Thoracoscopic repair of congenital diaphragmatic hernia in children. Semin Pediatr Surg. Nov 2007;16(4):238-44. [Medline].

  29. Bohn DJ, Pearl R, Irish MS, Glick PL. Postnatal management of congenital diaphragmatic hernia. Clin Perinatol. Dec 1996;23(4):843-72. [Medline].

  30. Karamanoukian HL, Glick PL, Wilcox DT, et al. Pathophysiology of congenital diaphragmatic hernia. VIII: Inhaled nitric oxide requires exogenous surfactant therapy in the lamb model of congenital diaphragmatic hernia. J Pediatr Surg. Jan 1995;30(1):1-4. [Medline].

  31. Sreenan C, Etches P, Osiovich H. The western Canadian experience with congenital diaphragmatic hernia: perinatal factors predictive of extracorporeal membrane oxygenation and death. Pediatr Surg Int. Mar 2001;17(2-3):196-200. [Medline].

  32. Ting A, Glick PL, Wilcox DT, Holm BA, Gil J, DiMaio M. Alveolar vascularization of the lung in a lamb model of congenital diaphragmatic hernia. Am J Respir Crit Care Med. Jan 1998;157(1):31-4. [Medline].

  33. Wung JT, Sahni R, Moffitt ST, Lipsitz E, Stolar CJ. Congenital diaphragmatic hernia: survival treated with very delayed surgery, spontaneous respiration, and no chest tube. J Pediatr Surg. Mar 1995;30(3):406-9. [Medline].

Further Reading

Keywords

congenital diaphragmatic hernia, CDH, posterolateral diaphragmatic hernia, Bochdalek hernia, retrosternal hernia, Morgagni's hernia, respiratory distress, pulmonary hypoplasia, pulmonary hypertension, pulmonary immaturity, neural tube defects, polyhydramnios, hydrops fetalis, cystic adenomatoid malformation, cystic teratoma, thymic cysts, foregut duplication cyst, neurogenic tumors, feeding intolerance, tachycardia, intestinal obstruction, bowel ischemia, necrosis, volvulus, ventricular hypoplasia, atrial septal defects, ventricular septal defects, metabolic acidosis, persistent-newborn pulmonary hypertension

Contributor Information and Disclosures

Author

Nicola Lewis, MBBS, FRCS, Specialist Registrar, Department of Surgery, Birmingham Children's Hospital, UK
Disclosure: Nothing to disclose.

Coauthor(s)

Philip Glick, MD, MBA, Professor, Departments of Surgery, Pediatrics, and Gynecology and Obstetrics, Vice-Chairperson for Research and Development, Department of Surgery, State University of New York at Buffalo
Philip Glick, MD, MBA is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Medical Association, American Pediatric Surgical Association, American Thoracic Society, Association for Academic Surgery, Association for Surgical Education, Central Surgical Association, Federation of American Societies for Experimental Biology, Medical Society of the State of New York, Phi Beta Kappa, Physicians for Social Responsibility, Royal College of Surgeons of England, Sigma Xi, Society for Pediatric Research, Society for Surgery of the Alimentary Tract, Society of Critical Care Medicine, and Society of University Surgeons
Disclosure: Nothing to disclose.

Medical Editor

Robert K Minkes, MD, PhD, Professor of Surgery, University of Texas Southwestern; Chief of Surgical Services, Children's Medical Center of Dallas-Legacy
Robert K Minkes, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Medical Association, American Pediatric Surgical Association, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Andre Hebra, MD, Chief, Division of Pediatric Surgery, Medical University of South Carolina; Professor of Surgery and Pediatrics, Medical University of South Carolina
Andre Hebra, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Medical Association, American Pediatric Surgical Association, Association for Academic Surgery, Society of Laparoendoscopic Surgeons, South Carolina Medical Association, Southeastern Surgical Congress, and Southern Medical Association
Disclosure: Nothing to disclose.

CME Editor

H Biemann Othersen Jr, MD, Professor of Surgery and Pediatrics, Emeritus Head, Division of Pediatric Surgery, Medical University of South Carolina
H Biemann Othersen Jr, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Association for the Surgery of Trauma, American Burn Association, American Cancer Society, American College of Surgeons, American Medical Association, American Pediatric Surgical Association, American Society for Parenteral and Enteral Nutrition, American Surgical Association, American Thoracic Society, British Association of Paediatric Surgeons, Society for Surgery of the Alimentary Tract, Society of Critical Care Medicine, South Carolina Medical Association, Southeastern Surgical Congress, Southern Medical Association, Southern Society for Pediatric Research, and Southern Thoracic Surgical Association
Disclosure: Nothing to disclose.

Chief Editor

Marleta Reynolds, MD, Professor of Surgery, Feinberg School of Medicine, Northwestern University; Interim Head, Division of Pediatric Surgery, Department of Surgery, Children's Memorial Hospital of Chicago
Marleta Reynolds, MD is a member of the following medical societies: American Pediatric Surgical Association
Disclosure: Nothing to disclose.

RELATED MEDSCAPE ARTICLES
Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.